Berit Müller - Concepedia

Author

Berit Müller

Also Known As

B M Müller, B Müller, B. M. Müller, B. Müller, B.M. Müller, Berit M Müller, Berit M. Müller, Berit M. Müller, Berit Maria Müller, Berit Müller

111

Publications

5.7K

Citations

H-Index

Concepts

All Affiliations

Charité - Universitätsmedizin Berlin German Breast group Siemens (Germany)Siemens Healthcare (Germany)Goethe University Frankfurt

About

Berit Müller is an author at Charité - Universitätsmedizin Berlin specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	3.1K
2	Engineering	3	3	202
3	Biochemistry	2	2	256
4	Biostatistics	2	2	334
5	Health Sciences	1	1	74

Berit Müller

Publications

5.6K

Citations

H-Index

Page 1

	Year	Citations
Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer Carsten Denkert, Sibylle Loibl, Aurelia Noske, Journal of Clinical Oncology Breast OncologyImmunologyPathologyImmunotherapeuticsImmunotherapy	2009	1.8K
Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression Mika Hilvo, Carsten Denkert, Laura Lehtinen, Cancer Research	2011	529
Neoadjuvant Chemotherapy and Bevacizumab for HER2-Negative Breast Cancer Gϋnter von Minckwitz, Holger Eidtmann, Mahdi Rezai, New England Journal of Medicine	2012	528
Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial Carsten Denkert, Sibylle Loibl, Berit Müller, Annals of Oncology Breast OncologyMedicineKi67 LevelsNeoadjuvant Gepartrio TrialPathology	2013	244
Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer - overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression Berit Müller, Lisa Jana, Atsuko Kasajima, BMC Cancer	2013	242
Androgen receptor expression in primary breast cancer and its predictive and prognostic value in patients treated with neoadjuvant chemotherapy Sibylle Loibl, Berit Müller, Gϋnter von Minckwitz, Breast Cancer Research and Treatment Breast OncologyMedicinePrognostic ValuePathologyBreast Cancer	2011	203
Comparative metabolomics of estrogen receptor positive and estrogen receptor negative breast cancer: alterations in glutamine and beta-alanine metabolism Jan Budczies, Scarlet Brockmöller, Berit Müller, Journal of Proteomics Breast OncologyBiochemistryBeta-alanine MetabolismMedicineEstrogen Receptor	2013	181
Ki67 Measured after Neoadjuvant Chemotherapy for Primary Breast Cancer Gϋnter von Minckwitz, Wolfgang Schmitt, Sibylle Loibl, Clinical Cancer Research	2013	173
Remodeling of central metabolism in invasive breast cancer compared to normal breast tissue – a GC-TOFMS based metabolomics study Jan Budczies, Carsten Denkert, Berit Müller, BMC Genomics	2012	151
A prognostic gene expression index in ovarian cancer—validation across different independent data sets Carsten Denkert, Jan Budczies, Silvia Darb‐Esfahani, The Journal of Pathology	2009	138

Page 1